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Abstract
Peroxisomes perform a range of metabolic functions which require the movement of substrates, co-substrates, cofactors and metabolites across
the peroxisomal membrane. In this review, we discuss the evidence for and against specific transport systems involved in peroxisomal metabolism
and how these operate to co-ordinate biochemical reactions within the peroxisome with those in other compartments of the cell.
© 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Peroxisomes are near-ubiquitous organelles of eukaryotic
cells which perform a range of functions, many of which are
organism- or tissue-specific [1,2]. The common metabolic
activities of peroxisomes are the oxidation of fatty acids and
generation and removal of hydrogen peroxide, but peroxisomes
have also been implicated in β-oxidation of aromatic and cyclic
compounds, synthesis of plasmalogens, isoprenoids, penicillin,
lysine and glycine betaine, metabolism of purines and
pyrimidines, and catabolism of polyamines, D-amino acids
and methanol. Dependent on the organism, these organelles also
participate in the glyoxylate cycle, pentose phosphate pathway
and photorespiration and key roles for peroxisomes in signalling
and development have emerged recently ([3,4], and references
therein). This diversity of function is often reflected in
peroxisomal specialisation, especially in plants [5] and also in
trypanosomes [6,7].
The multiple roles of peroxisomes imply not only that a
relatively large number of chemically diverse solutes must enter
the peroxisome, but also that the products of peroxisomal
metabolism must be exported from the organelle. Moreover,
since a number of pathways are shared between the peroxisome
and other cellular compartments, the metabolic steps that occur
within the peroxisomal matrix or on the inner face of the
peroxisomal membrane must be integrated with those in other
cellular compartments to permit efficient operation of biochem-
ical pathways.
The transport properties of the peroxisomal membrane have
been a controversial issue for several decades. Early studies
with isolated organelles revealed a lack of structure-linked
latency for certain peroxisomal enzymes, suggesting that these
organelles are freely-permeable to substrates (for more details
see Antonenkov and Hiltunen, this issue). Although critics of
this hypothesis have argued that the in vitro permeability of the
membrane reflects damage and disruption during isolation (e.g.
[1]), there have been a number of reports of relatively non-
specific porin-like proteins in the peroxisomes of mammals,
plants and yeast (reviewed in [8]). Recent, rigorous studies with
isolated peroxisomes indicate that these organelles are perme-
able to low molecular weight, hydrophilic solutes such as
glycolate and urate, but not to more bulky cofactors [9]. The
latter conclusion is strongly supported by genetic studies which
demonstrate that the peroxisomal membrane of Saccharomyces
cerevisiae is impermeable to NAD(H) and acetyl-CoA in vivo
[10]. Although the functions of many peroxisomal membrane
proteins remain unknown, a growing number of peroxisomal
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transport proteins have been characterised at the molecular level
and these form the subject of this review. Of these, the best
characterised are the adenine nucleotide translocator and ATP-
binding cassette (ABC) transporters which have been impli-
cated in transport of substrates for β-oxidation.
2. Import of substrates, co-substrates, and cofactors for
β-oxidation
2.1. Import of substrates for β-oxidation: the role of
ABC transporters
β-Oxidation not only provides a major pathway for the
degradation of fatty acids but also serves a synthetic role in the
production of a range of bioactive, lipid-derived molecules such
as jasmonates, plasmalogens and bile acids [1,11]. In yeast and
plants, the peroxisome is the sole site of fatty acid β-oxidation,
whereas in mammals, very long chain fatty acids (VLCFA) are
first chain-shortened in the peroxisome prior to complete
oxidation in mitochondria. Oxidation of long chain fatty acids
(LCFA) is predominantly mitochondrial and short- and medium
chain fatty acids (S- and MCFA) are oxidised exclusively in
mitochondria. In all cases, formation of fatty acyl-CoA esters is
a prerequisite for entry into the β-oxidation spiral and is
catalysed by members of a family of acyl-CoA synthetase
enzymes, also known as activases, which differ in their substrate
specificity. The intracellular location of fatty acid activation
differs according to chain length and organism and thus
determines the identity of the molecular species which must
traverse the peroxisomal membrane. SCFA and MCFA are
considered to be readily membrane-permeable and are able to
enter mitochondria and peroxisomes in their protonated form.
Esterification of free fatty acid to CoA, however, generates an
amphipathic molecule, which is unable to cross membranes in
the absence of a transport protein. Genetic studies have
provided strong evidence for the involvement of members of
the ABC protein superfamily in the peroxisomal import of
substrates for β-oxidation [3].
A functional ABC protein comprises two copies each of
two units: the membrane spanning domain (MSD), also known
as the transmembrane domain (TMD) and the soluble
nucleotide binding fold (NBF) [12]. In eukaryotes, these
units are frequently contained within a single polypeptide with
the topology TMD-NBF-TMD-NBF, an arrangement com-
monly referred to as a “full size” transporter. Alternatively, two
“half size” transporters (TMD-NBF) may dimerise to form a
functional ABC protein. Peroxisomal ABC transporters belong
to subclass D, almost all members of which are half size
transporters. The ABCD subfamily contains between one and
five members and is represented in all eukaryotic taxa studied
to date [3,13–22], but has been most extensively studied in
mammals, baker's yeast and the model plant, Arabidopsis
thaliana.
2.1.1. Yeast
Saccharomyces cerevisiae contains two peroxisomal ABC
transporters, Pxa1p and Pxa2p (also known as Pat2p/Pal1p and
Pat1p), which have been shown by genetic and co-immuno-
precipitation studies to form a functional heterodimer in the
peroxisomal membrane [23–26]. pxa1Δ and pxa2Δ deletion
mutants are unable to grow on the LCFA oleate as the sole
carbon source, but growth on MCFA such as laureate was
unaffected, suggesting that these transporters play a specific
role in β-oxidation of LCFA. This agrees with the finding that
MCFA are imported into the peroxisome as free fatty acids
where they are activated by the acyl-CoA synthetase Faa2p
[23]. In contrast, LCFA are activated in the cytosol and LCFA-
CoA esters must be transported across the peroxisomal
membrane (Fig. 1). Biochemical studies with permeabilised
spheroplasts provided evidence that Pxa2p is required for
import of LCFA-CoA but not of SCFA-CoA [27] and
mistargeting of Faa2p to the cytosol was shown to make β-
oxidation of MCFA dependent on Pxa1p/Pxa2p [23],
providing further support that this is an acyl-CoA transporter
[28].
2.1.2. Plants
The genome of Arabidopsis thaliana contains a single
ABCD gene, known as COMATOSE (CTS) and also as PXA1,
PED3 and AtABCD1 [15,29,30]. Interestingly, unlike non-plant
ABCD proteins, CTS is a full-length ABC transporter, in which
two dissimilar half-size units are contained in a single
polypeptide. All plant ABCD proteins identified to date have
this modular architecture, suggesting that the fusion of two
halves was a single, ancient event in evolutionary history. CTS
is expressed ubiquitously in Arabidopsis and, unsurprisingly,
null alleles have a pleiotropic phenotype: cts mutants fail to
germinate in the absence of classical dormancy-breaking
treatments and seedlings require sucrose for establishment
[15,31]. Oil bodies and fatty acyl-CoAs, particularly VLCFA-
CoAs, are retained in mutant seedlings, indicating an inability to
break down storage lipid [15]. It has been suggested therefore,
that CTS either transports or regulates the import of fatty acids
or fatty acyl-CoAs into the peroxisome [3,11,15,29,30]. The
transported species is still a matter for debate: whilst the
retention of VLCFA-CoA is suggestive that CTS transports
acyl-CoA, it is possible that the CoA pool represents a sink for
free fatty acids and thus that CoA retention does not reflect
cytosolic accumulation of CTS substrates. Moreover, the
characterisation of a double peroxisomal acyl-CoA synthetase
mutant provides evidence that free fatty acids could be
transported into plant peroxisomes. Arabidopsis has two
peroxisomal acyl-CoA synthetases (LACS 6 and 7) which
have a substrate preference for (V)LFCA [32]. The active sites
of LACS 6 and 7 are within the peroxisome and the lacs6, lacs7
double mutant is unable to degrade storage lipid and cannot
establish in the absence of sucrose [32,33]. Furthermore,
peroxisome morphology of β-oxidation mutants such as kat2
(thiolase) and mfp2 (multifunctional protein) is distorted due to
intraperoxisomal accumulation of acyl-CoAs [34,35], whereas
it is normal in cts and lacs6, lacs7, suggesting that knocking
out either the CTS transporter or the peroxisomal acyl-CoA
synthetases prevents accumulation of acyl-CoAs in peroxi-
somes [36].
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Other aspects of the cts mutant phenotype suggest that CTS
could be a transporter of broad substrate specificity. Roots of
cts mutants are resistant to indole butyric acid (IBA) and 2,4
dichlorophenoxybutyric acid (2,4-DB), indicating that they are
unable to metabolise these compounds by β-oxidation to the
corresponding active auxins [15,29,30]. The simplest explana-
tion for these data is that CTS transports IBA and 2,4-DB or
their CoA esters. Both basal and wound-induced jasmonic acid
(JA) levels are reduced in cts mutants, suggesting that CTS is
also involved in peroxisomal import of jasmonate precursors
which yield JA following reduction by the peroxisomal enzyme
OPR3 and three rounds of β-oxidation [37]. Many JA
biosynthetic and signalling mutants are male sterile but cts
mutants apparently have sufficient JA to retain fertility,
suggesting an additional, probably passive, route for import
of JA precursors. Nevertheless, fertilisation is reduced in cts
mutants, which exhibit defects in pollen tube growth. This
phenotype is not rescued by application of JA, suggesting an
additional role for CTS in optimal fertility in Arabidopsis (S.
Footitt, D. Dietrich, A. Baker, M. Holdsworth and F.
Theodoulou, unpublished data). Taken together, comparisons
of the phenotypes of cts mutants with those defective in other
steps of β-oxidation is pointing to a role of β-oxidation not
only in energy metabolism but also in the generation or
processing of developmental signals and new roles for
peroxisomal metabolism may await discovery in plants. An
exciting challenge for the future will be the determination of
the precise biochemical role of CTS, which awaits transport
studies.
2.1.3. Mammals
The ABCD subfamily of humans and mice has four
members: Adrenoleukodystrophy protein (ALDP; ABCD1),
Adrenoleukodystrophy related protein (ALDR; ABCD2),
PMP70 (ABCD3) and PMP69 (P70R; ABCD4), which exhibit
overlapping but distinct tissue expression patterns [38–43].
These proteins have been shown to be integral peroxisomal
membrane proteins [40,41,43–46] and a search for interacting
partners revealed that ALDP, ALDR and PMP70 interact with
PEX19, a cytosolic acceptor for peroxisomal membrane
proteins which is involved in their intracellular sorting and
trafficking to the peroxisomal membrane [47–50].
PMP70 was the first peroxisomal ABC transporter to be
identified and characterised functionally and is expressed
predominantly in liver [40], but transcripts have been
detected in all tissues investigated [41]. Overexpression of
rat PMP70 in Chinese hamster ovary cells led to an increase
in LCFA but not VLCFA β-oxidation by peroxisomes and
site-directed mutagenesis demonstrated a requirement for
conserved motifs in ATP binding and hydrolysis [51].
Unlike many genes encoding peroxisomal proteins, muta-
tions in ABCD3 are not associated with disease in humans
and the physiological significance of PMP70 awaits
investigation [52,53]. Preliminary reports from abcd3−/−
knockout mice suggest an additional role in transport of 2-
methylacyl-CoA esters [54]. On the basis of sequence
homology, PMP69 has been suggested to play a similar
role to PMP70, though this transporter has not yet been
characterised functionally [38].
Fig. 1. Transport processes associated with β-oxidation. Dependent on chain length and organism, fatty acids are imported into peroxisomes as free acids (FFA) or
CoA esters (FA-CoA). CoA esters formed in the cytosol or on the endomembrane system by the action of acyl-CoA synthetases (ACS) are transported across the
peroxisomal membrane by one or more ABC proteins, at the expense of ATP hydrolysis. Alternatively, short- and medium chain free acids may enter the peroxisome
by passive transport and are activated by peroxisomal ACS. This reaction requires intraperoxisomal pools of ATP and CoA which are supplied by the peroxisomal
adenine nucleotide translocator (ANT) and by an unknown mechanism (?) respectively. AMP and pyrophosphate (PPi) are produced as by-products of fatty acid
activation; AMP is exchanged for ATP by ANT and pyrophosphate is thought to be converted to inorganic phosphate which is exported by an NEM-insensitive
phosphate transport protein (PT).
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ALDP has received much attention due to its role in the X-
linked neurodegenerative disease, Adrenoleukodystrophy (X-
ALD), which is characterised biochemically by the accumula-
tion of VLCFA in plasma and tissue. Although X-ALD was
originally associated with reduced activity of VLC acyl-CoA
synthetase [55–57], positional cloning identified the ALD gene
as an ABC transporter [42] and transfection with the wild type
ABCD1 cDNA was shown to correct the VLCFA β-oxidation
defect of X-ALD fibroblasts [58–60]. Currently, over 650
different mutations in the ABCD1 gene have been reported [52;
www.X-ALD.nl]; in the majority of cases investigated,
immunoreactive ALD protein is absent, suggesting the existence
of an efficient retrieval mechanism for mutant forms of ALDP or
that non-functional ALDP is unstable [46,61,62]. The precise
relationship between the clinical symptoms of X-ALD, the
biochemical phenotype and mutated ABCD1 is not currently
clear [63,64]; for example, mouse models have been developed
for X-ALD and although abcd1−/− mice replicate the
biochemical defects of patients, they do not exhibit the clinical
and pathological symptoms until very late in life [65–67]. It has
been proposed that elevated VLCFA levels in X-ALD are related
to mitochondrial dysfunction [68], although this has been
contested by a detailed ultrastuctural study of mitochondria [69].
Enhanced microsomal fatty acid chain elongation has also been
suggested as an additional mechanism underpinning VLCFA
accumulation in X-ALD [70]. Despite the uncertainty regarding
the pathology of X-ALD, it remains plausible that ALDP is a
VLCFA or VLCFA-CoA transporter [52], and support for this
hypothesis has been obtained by substrate-induced conforma-
tional changes [71], although unequivocal proof awaits direct
demonstration of transport activity for purified ALDP.
Complementation studies have shown that expression of
ALDRP and, surprisingly, PMP70 restores VLCFA β-oxidation
in X-ALD fibroblasts, preventing VLCFA accumulation
[58,63,72–74]. Pharmacological induction of endogenous
peroxisomal transporters also resulted in restoration of
VLCFA β-oxidation, providing promising leads for therapy
[73,74]. These data suggest that mammalian peroxisomal ABC
transporters are at least partially redundant and functional
overlap between ALDP and ALDR has been confirmed by
studies with knockout mice [75].
It has been suggested by several authors that the four half
size transporters of the mammalian ABCD subfamily might
heterodimerise to yield variants with modified transport
properties [39,43,76], by analogy to human transporters
associated with antigen processing (TAP) belonging to ABC
subfamily B [77]. A number of studies have provided evidence
for both homo- and heterodimerisation of ALDP, ALDR and
PMP70 in vitro [63,78,79]. However, the expression patterns
imply that, in several cell types, heterodimerisation is not
physically possible in vivo [41,80,81] and this view is supported
by the differential induction by pharmacological agents [82].
Moreover, purification of native ALDP and PMP70 strongly
suggest that homomeric interactions predominate in vivo [83].
Nevertheless, heterodimerisation cannot be ruled out under
specific conditions and is an important consideration for X-
ALD gene therapy.
2.2. Transport of adenine nucleotides
The peroxisomal transporter best characterised is the adenine
nucleotide transporter of S. cerevisiae, which is required for the
activation of MCFA, the only established ATP-consuming
reaction inside peroxisomes (Fig. 1). As discussed above, while
the cytosolic fatty acid activation enzymes preferentially use
LCFA as substrates, peroxisomes are the predominant site for
MCFA activation [23]. The latter reaction is dependent on the
supply of intraperoxisomal ATP and is catalysed by perox-
isomal acyl-CoA synthetase Faa2p. Upon formation of the fatty
acyl-CoA product, AMP is generated, which has to be exported
back to the cytosol due to the lack of an adenylate kinase or an
ATP regeneration system within peroxisomes. This cross-
membrane traffic of adenine nucleotides (ATP in, AMP out) is
catalysed by Ant1p [84,85], a member of the mitochondrial
carrier family (MCF) generally involved in solute transport
[86]. Both genetic and biochemical evidence supports this view:
cells mutated in either FAA2 or ANT1 grow normally on LCFA
but fail to do so on MCFA. In combination with a disabled
Pxa1p–Pxa2p transporter, the faa2Δ and the ant1Δ mutants are
unable to metabolise any fatty acid [23,84,85]. The β-oxidation
rates of MCFA of an ant1Δ strain are also reduced when
measured with intact cells. However, the respective cell lysates
show a normal level of β-oxidation, which is consistent with a
blockage in the ATP transport across the peroxisomal
membrane in intact ant1Δ cells [85]. Likewise, heterologous
expression of a peroxisomally targeted luciferase, which emits
light in an ATP-dependent manner, required Ant1p for activity,
but not when assayed in cell lysates [85].
Functional reconstitution of purified Ant1p into liposomes
revealed the ability of Ant1p to transport adenine nucleotides
specifically. ATP uptake was measured with proteoliposomes
loaded with ATP, ADP, AMP, or the respective desoxynucleo-
tides, whereas uptake was very low with other nucleotides or a
number of other substrates for various known transporters [84].
The established inhibitors of the mitochondrial ADP/ATP
carrier, carboxy atractyloside and bongkrekic acid [87] did not
reduce the activity of Ant1p, indicating that Ant1p represents a
novel type of MCF transporter. Interestingly, Ant1p exhibits
two transport modes, not only the exchange described above,
but also the uniport of adenine nucleotides [88]. In vivo, the
former mode serves to exchange ATP for AMP under ongoing
β-oxidation, whereas the latter is probably most important for
loading peroxisomes with ATP early in their genesis (Fig. 1).
Since both modes are proton-compensated and electroneutral
[88], import of negatively charged ATP should contribute to the
formation of a proton gradient across the peroxisomal
membrane. Consistent with this idea, the ΔpH across the
peroxisomal membrane is significantly diminished in an ant1Δ
knock-out strain as measured by pH-sensitive variants of
fluorescent proteins [88,89]. The significance of such measure-
ments will be discussed below.
Pmp47p from Candida boidinii represents a functional
homolog of Ant1p. Sakai and colleagues showed that a
pmp47Δ mutant also exhibits a specific growth defect on
MCFA, which can be rescued by introducing S. cerevisiae Faa2p
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devoid of its peroxisomal targeting signal [90]. Growth on
MCFAwas also restored upon expression of cytosolic Faa2p in
S. cerevisiae ant1Δ cells [85] providing evidence that Pmp47p
and Ant1p function as peroxisomal ATP carriers. Given that
MCFA are now activated by truncated Faa2p in the cytosol and
transported into peroxisomes through Pxa1p–Pxa2p, intraper-
oxisomal ATP becomes dispensable. That heterologous expres-
sion of PMP47 is able to restore growth of the S. cerevisiae
ant1Δ mutant on MCFA [84] lends further credence to the
conception that Pmp47p represents the C. boidinii ortholog of
Ant1p.
The human MCF member PMP34 localises to peroxisomes
and its sequence is closely related to Pmp47p and Ant1p [91].
PMP34 likely represents the mammalian ortholog of Ant1p, as
it was able to partially complement the MCFA β-oxidation
defect of the ant1Δ mutant, and showed some ATP exchange
activity when reconstituted into liposomes [92]. However, due
to the current lack of reports on the effects of PMP34 knock-
down by RNAi or on PMP34 knock-out mice, its physiological
role remains elusive.
A proteomic approach has led to the identification of a
candidate peroxisomal adenine nucleotide translocator from
Arabidopsis. PMP38 exhibits 25% and 26% amino acid identity
to human PMP34 and C. boidinii PMP47, respectively and was
shown by a combination of cell fractionation and immunocy-
tochemical analysis to be an integral peroxisomal membrane
protein [93]. Although the pattern of developmental changes in
PMP38 abundance strongly suggest involvement in β-oxida-
tion, the in vivo function has yet to be determined, for example,
by characterisation of knock-out mutants or antisense lines.
2.3. CoA and phosphate transport
Peroxisomal acyl-CoA synthetases such as yeast Faa2p as
well as 3-ketoacyl-CoA thiolases require free CoA within
peroxisomes. Although some CoA probably enters the
peroxisomal matrix thioesterified with LCFA via the Pxa1p–
Pxa2p transporter of yeast, stoichiometry suggests that a certain
pool of CoA must be provided by other means to maintain
MCFA activation and the flux through the β-oxidation spiral.
Furthermore, activation and degradation of MCFA occur
normally in pxa1Δpxa2Δ mutant cells [23]. It is currently
unclear whether peroxisomes contain a CoA transporter as has
been suggested for mitochondria. Here, the MCF member
Leu5p is required for the accumulation of CoA in the
mitochondrial matrix and the related human Grave's disease
protein can functionally replace Leu5p [94]. It is not entirely
impossible that this carrier also localises to peroxisomes.
Intraperoxisomal ATP-dependent fatty acid activation gene-
rates pyrophosphate that probably decomposes into two
molecules of orthophosphate, which have to leave the
peroxisome for regeneration of ATP. Evidence for a phosphate
transporter was recently provided using proteoliposomes
reconstituted from peroxisomal membranes that had been
purified from bovine kidney [95]. Although the molecular
identity of this transporter remains to be determined, it differed
from the mitochondrial transporter in terms of sensitivity
towards N-ethylmaleimide (NEM) and p-hydroxyphenyl-
glyoxal (PHGP), as only the mitochondrial activity was
adversely affected by these compounds [95].
2.4. Import of cofactors and regeneration of reducing
equivalents
Genetic studies and transport assays utilising isolated
peroxisomes suggest that the peroxisomal membrane is not
freely permeable to bulky cofactors, implying that the
peroxisome has separate pools of NAD+, NADP+, and FAD
[9,10]. Acyl-CoA oxidase absolutely requires FAD, but the
holoenzyme is assembled in the cytosol and is imported into
peroxisomes as a folded protein [96]. Alcohol oxidase from
methylotrophic yeasts also binds its cofactor in the cytosol,
although in this case the assembly into an active octamer occurs
inside peroxisomes [97,98]. Thus it appears likely that
peroxisomal FAD-containing oxidases generally acquire their
cofactor in the cytosol, and a peroxisomal FAD transporter
might not be required. Peroxisomal FAD is reoxidised with the
concomitant generation of H2O2 which in turn is removed by
catalase. This situation contrasts with the import of FAD into
mitochondria: the mitochondrial inner membrane has at least
two specific FAD transporters, with Flx1p representing a FAD
exporter [99], but in this organelle proteins traverse the
membrane in an unfolded state which necessitates an intrami-
tochondrial cofactor charging of the apo-flavoenzymes.
NADH is produced in the course of β-oxidation by the
dehydrogenase reaction of the multifunctional enzyme and must
be regenerated via one or more redox shuttles analogous to
those in mitochondria. In mammals, pyruvate or dihydroxya-
cetone phosphate are likely to serve as the electron acceptors,
through the action of lactate dehydrogenase [100,101] and
glycerol-3-phosphate dehydrogenase [102], respectively. In
contrast, in yeast [10] and plants (Pracharoenwattana and
Smith, personal communication), the electrons are transferred to
oxaloacetate, which is converted to malate by peroxisomal
malate dehydrogenase. This could operate in the context of two
different shuttles: a malate-oxaloacetate shuttle, or a malate-
aspartate shuttle in which reducing equivalents are transferred
from peroxisomes to mitochondria [10,103]. The former is a
simpler scenario in which malate is exported to the cytoplasm,
where it is re-oxidised by cytosolic malate dehydrogenase to
oxaloacetate, which re-enters the peroxisome (Fig. 2A). NADH
produced by cytosolic malate dehydrogenase is then re-oxidised
by mitochondrial NADH dehydrogenases. The alternative
malate-aspartate shuttle was originally proposed due to the
fact that the inner mitochondrial membrane is relatively im-
permeable to oxaloacetate. In this case, oxaloacetate is not
imported into the peroxisome, but rather is generated from
aspartate and 2-oxoglutarate with the concomitant formation of
glutamate in a transamination reaction catalysed by aspartate
amino transferase [103,104]. This requires exchange of malate/
2-oxoglutarate and glutamate/aspartate across the peroxisomal
and mitochondrial membranes (Fig. 2B). However, this scheme
has been contested by biochemical studies with leaf peroxi-
somes [105] and disruption of the AAT2 gene of yeast does not
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affect growth on oleate, indicating that it is not essential for the
regeneration of intraperoxisomal NAD+ [106].
Regardless of the specific redox shuttle involved in
regeneration, in all cases, NAD(H) must move back and forth
from the multifunctional enzyme to a dehydrogenase and is
therefore only transiently bound to the enzymes. It might be that
NAD+ is imported in the manner of FAD through cytosolic
association and subsequent joint transit with NAD+-dependent
enzymes. Whether such a mechanism would be sufficient to
establish the peroxisomal pool of NAD(H) remains unclear. It
appears more likely that additional, low efficiency routes for
provision of peroxisomal NAD+ exist.
Similar arguments account for the supply of peroxisomes
with NADP+. This cofactor is required for the β-oxidation
auxiliary enzyme Δ2-Δ4-dienoyl-CoA reductase, which is
essential for the degradation of unsaturated fatty acids with
double bonds at even-numbered positions [107]. NADPH is
regenerated inside peroxisomes via an isocitrate/2-oxoglutarate
shuttle [108–110], similar to that which links the mitochondrial
and cytosolic pools of NADPH in rat liver (Fig. 3). Oxidation of
isocitrate is catalysed by the peroxisomal NADP+-dependent
isocitrate dehydrogenase, Idp3p. This reaction regenerates
NADPH and yields 2-oxoglutarate which is exported from the
peroxisome and is possibly re-reduced to isocitrate by the
cytosolic isocitrate dehydrogenase, Idp2p. The reverse reduc-
tive carboxylation of 2-oxoglutarate appears feasible under
physiological conditions, since the Km values of Idp2p are
similar for isocitrate and 2-oxoglutarate, albeit Vmax is about 20
times lower for the latter substrate [111]. The shuttle is thought
to be completed by the import of isocitrate into the peroxisome
[109,110], but the carriers required for shuttling of isocitrate and
2-oxoglutarate remain elusive. An alternative route for the
peroxisomal regeneration of NADPH involves glucose-6-
phosphate dehydrogenase [112].
The operation of an isocitrate/2-oxoglutarate shuttle or a
glucose-6-phosphate dehydrogenase-dependent mechanism for
NADPH regeneration in plant peroxisomes still requires
experimental confirmation, although genes encoding a number
of the requisite components have been identified at least in
silico [104]. However, the identity of the dicarboxylate carriers
which function in peroxisomal redox shuttles remains obscure.
Mitochondria contain several dicarboxylate carriers which
might co-target to peroxisomes [86]. Small amounts of specific
carriers might have escaped detection in the various proteomic
approaches aimed at identifying peroxisomal membrane
proteins due to the prevalent problem of mitochondrial
contamination [113,114]. Alternatively, peroxisomal porins
which have not yet been identified at the molecular level
could be responsible for transport of shuttle metabolites (see
Antonenkov and Hiltunen, this issue).
2.5. Nudix hydrolases and regulation of cofactor and co
substrate concentration
In addition to import and regeneration, export must be
considered as a factor affecting the intraperoxisomal pools of
NAD(P)H and CoA. Nudix hydrolases comprise a diverse
family of enzymes which hydrolyse a diphosphate linkage in a
variety of nucleotide-containing compounds and appear to play
an important role in the regulation of intraperoxisomal cofactor
concentration and possibly removal of damaged cofactors
[115]. Peroxisomal representatives identified to date include
Fig. 2. Transport of reducing equivalents. The dehydrogenase reaction of the
multifunctional protein of β-oxidation requires NAD+. Since the peroxisomal
membrane is impermeable to nucleotides and nucleotide-containing cofactors,
two redox shuttles involved in regeneration of peroxisomal NAD+ have been
proposed for plants and yeast. Both systems require exchange of organic anions
across the peroxisomal membrane, which may be executed by specific carriers
or porin-like proteins. (A) The malate-oxaloacetate shuttle. Peroxisomal malate
dehydrogenase (MDH) converts oxaloacetate (OAA) to malate with the
concomitant oxidation of NADH. Malate is exported to the cytosol, where it
is re-converted to OAA by the action of cytosolic MDH. NADH produced in this
reaction is re-oxidised by mitochondrial NADH dehydrogenases (NDH). Import
of OAA into the peroxisome completes the shuttle. Abbreviations: ACX, acyl-
CoA oxidase; MFP, multifunctional protein; thio, thiolase. (B) The malate-2-
oxoglutarate shuttle. As in the malate-oxaloacetate shuttle, malate produced
from OAA by peroxisomal MDH is exported from the peroxisome. Malate is
then transported into mitochondria where it is converted to OAA byMDH. OAA
then undergoes conversion to aspartate by aspartate amino transferase (AAT),
with the concomitant formation of 2-oxoglutarate (2-OG) from glutamate. 2-OG
is transferred from mitochondria to peroxisomes where the reverse reaction
occurs, catalysed by peroxisomal aspartate amino transferase, to yield OAA.
This shuttle also requires the transport of aspartate and glutamate between
mitochondria, peroxisomes and cytosol. Redrawn from Elgersma and Tabak
[154].
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NAD(P)H diphosphatases which exhibit substrate preference
for reduced dinucleotides [116,117] and CoA diphosphatases,
which handle CoA, CoA esters and oxidised CoA with
differing efficiency [118–121]. Importantly from a transport
perspective, these enzymes have the net effect of degrading
bulky cofactors to smaller molecules which can readily exit the
peroxisome.
3. Export of acetyl- and acyl-units
The export of acetyl-CoAs generated by peroxisomal
β-oxidation is accomplished by either of two systems, a
carnitine shuttle or through the export of citrate. This is because
acetyl-CoA is not able to readily traverse the peroxisomal
membrane, whereas the compounds produced are. The relative
importance of the two modes varies between species. Genetic
evidence indicates that both systems operate in yeast [10],
whereas in plants only citrate export occurs [122]. Mammals
lack the glyoxylate cycle and a peroxisomal citrate synthase does
not exist, suggesting that here the carnitine-mediated export is
the exclusive mode of acetyl-removal. An alternative route,
which predominates in some mammalian tissues, is the export of
acetate generated from acetyl-CoA by the action of peroxisomal
thioesterases [1].
3.1. The carnitine shuttle
The existence of a carnitine shuttle is supported by the
localisation of yeast carnitine acetyl transferase Cat2p, which
is found in both mitochondria and peroxisomes [123]. In
peroxisomes, the enzyme is thought to catalyse transfer of the
acetyl moiety from CoA to carnitine, whereas in mitochon-
dria it would catalyse the reverse reaction thereby enabling
the condensation of acetyl-CoA with oxaloacetate to form
citrate. As a consequence, acetyl-carnitine has to traverse
both the peroxisomal as well as the inner mitochondrial
membrane. Mitochondrial transport is accomplished by the
carnitine carrier Crc1p, a member of the mitochondrial carrier
family, which transports acetyl-(and propionyl-) carnitine in
exchange for carnitine [124,125]. The important role the
CAT2 and CRC1 genes play in fatty acid utilisation is also
indicated by the induction of their expression in the presence
of oleate [126]. However, and in contrast to the dually
localised Cat2p transferase, the carnitine carrier is apparently
absent from the yeast peroxisomal membrane [125]. This is
also true for the Aspergillus nidulans carnitine carrier AcuH
[127,128]. Which peroxisomal protein therefore enables the
exit of acetyl-carnitine and the import of carnitine remains
elusive.
In mammals, carnitine octanoyl transferase with a substrate
preference for MCFAs additionally resides within peroxisomes
[1,129,130]. This enzyme is required because peroxisomal
β-oxidation usually does not go to completion. Rather, the
chain-shortened substrates are transported to mitochondria as
carnitine conjugates, where they are reconverted into the CoA
esters and further degraded by the resident β-oxidation
system. The broader substrate specificity of the mitochondrial
carnitine acylcarnitine carrier CAC, which also accepts longer
carnitine fatty acyl moieties, reflects the distinct distribution
of β-oxidation systems in mammals and yeast [131]. A cluster
of three carnitine transporters has been identified in the mouse
genome with distinct subcellular localisation and affinities for
carnitine. Recently, it has been suggested that OCTN3
encodes a peroxisomal medium-affinity carnitine transporter
[132,133]. Fusing OCTN3 to green fluorescent protein (GFP)
and immunogold labelling using anti-OCTN3 antibodies
revealed that this isoform of the family might indeed be a
predominantly peroxisomal protein. The antibodies also
reacted with a protein in human fibroblasts that was absent
in a pex19 patient cell line, in which the steady state
concentration of several PMPs is below the detection limit
due to a specific defect in peroxisome membrane biogenesis
[134]. In light of the fact that the OCTN transporters belong
to the organic cation transporter family that is not related to
the MCF, the relevance of a reported cross-reactivity of an
antibody against the mitochondrial carnitine carrier (CAC)
with a protein from purified rat peroxisomes remains unclear
[135].
Intriguingly, a carnitine acyl carrier homologue, BOU, has
also been identified in Arabidopsis mitochondria. bou mutant
plants exhibit a striking phenotype in which growth is arrested
after germination but lipids are still degraded [136]. However,
the function of this transporter in relation to peroxisomal
metabolism remains obscure, since higher plants possess neither
peroxisomal carnitine transferases nor a mitochondrial β-
oxidation system.
Fig. 3. The isocitrate-2-oxoglutarate shuttle. In addition to the chain-shortening
β-oxidation system, the oxidation of unsaturated fatty acids requires auxiliary
enzymes for the elimination of double bonds, including Δ2-Δ4-dienoyl-CoA
reductase (DECR) and Δ3-Δ2-enoyl-CoA isomerase which may be provided by
multifunctional protein (MFP) or by amonofunctional peroxisomalΔ3-Δ2-enoyl-
CoA isomerase (PECI). The requirement of DECR for NADPH requires a system
for the regeneration of peroxisomal NADPH. The isocitrate-2-oxoglutarate
shuttle which employs peroxisomal (Idp3p) and cytosolic (Idp2p) isocitrate
dehydrogenase has been proposed to occur in yeast and may also occur in plants.
Themechanism of isocitrate and 2-oxo-glutarate transport across the peroxisomal
membrane is unknown, but may involve specific carriers or porins which have
been shown to transport dicarboxylic acids. Abbreviations: ACX, acyl-CoA
oxidase; 2-OG, 2-oxoglutarate. Modified from van Roermund et al. [110].
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3.2. Carnitine-independent export from peroxisomes: the role
of thioesterases
In mammals, a carnitine-independent route for exporting
acyl units from peroxisomes has been demonstrated [1,137].
Here, CoA esters are hydrolysed within peroxisomes to yield
free acids which are transported to mitochondria and re-
activated to their respective CoA esters for completion of
β-oxidation. Hydrolysis of CoA esters is catalysed by peroxi-
somal thioesterases which vary in substrate specificity [138].
Interestingly, the Arabidopsis genome contains several
candidate peroxisomal thioesterases [104,139], one of which
(ACH2) has already been characterised [140]. In addition to
roles in fatty acid β-oxidation, these may play an important role
in the export of diverse, plant-specific metabolites synthesised
in the peroxisome. For example, the final biosynthetic steps of
the carboxylate-containing plant hormones, jasmonic acid and
indole acetic acid, occur in peroxisomes. Following one (IBA to
IAA) or three (OPDA to jasmonic acid) complete rounds of
peroxisomal β-oxidation, the hormones are thought to leave the
organelle as free acids, particularly in light of the absence of
peroxisomal carnitine transferases. This would require a
thioesterase-catalysed release from the CoA ester. Additional
roles proposed for peroxisomal thioesterases include the
regulation of acyl-CoA/free CoA levels and the prevention of
CoA sequestration by intermediates which are β-oxidised
inefficiently [138].
3.3. Diversion of acetyl-CoA through citrate synthase;
transport requirements of the glyoxylate cycle
Citrate synthase catalyses the formation of citrate from
oxaloacetate and acetyl-CoA with the liberation of free CoA.
Yeast peroxisomal citrate synthase Cit2p also participates in the
glyoxylate cycle, but is not essential for growth on nonfermen-
table carbon sources since the mitochondrial TCA cycle
isoforms Cit1p and/or Cit3p can substitute for Cit2p (for more
details, see Kunze et al., this issue). Acetyl-CoA generated
within peroxisomes during β-oxidation also does not accumu-
late in a cit2 deletion because of the redundant carnitine
Fig. 4. Transport requirements of the glyoxylate cycle. The enzymes of the glyoxylate cycle are located in both peroxisomes and cytosol and isocitrate lyase is
differentially localised in plants and fungi. This requires the transport of several different metabolites across the peroxisomal membrane but the precise biochemical
nature of the transport steps in the glyoxylate cycle is unknown. Note that this scheme requires cytosolic malate dehydrogenase (MDH): peroxisomal MDH does not
participate in the glyoxylate cycle, but rather operates in the reverse direction, in the regeneration of reducing equivalents shown in Fig. 2. The export of malate and
import of oxaloacetate (OAA) correspond to the malate-OAA shuttle (Fig. 2A). Abbreviations: CSY, citrate synthase; ACO, aconitase; ICL, isocitrate lyase; MLS,
malate synthase.
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conjugation system described above. However, by deleting both
CIT2 and CAT2 or CRC1, growth on oleate is abolished,
because now acetyl-CoA is trapped within peroxisomes.
In Arabidopsis, two glyoxysomal citrate synthases Csy2 and
Csy3 fulfil an analogous function in β-oxidation, with the
difference that a carnitine bypass does not operate [122]. The
double csy2, csy3 mutant therefore exhibits an extremely severe
phenotype: like cts and other strong β-oxidation alleles
[31,141], csy2, csy3 seeds are dormant and will only germinate
when the seed coat is removed and sucrose is supplied.
Moreover, rescued seedlings do not develop further when
transferred to soil, indicating the importance of citrate export in
plant growth and development [122].
Citrate produced by peroxisomal metabolism is exported to
the cytosol and ultimately enters the mitochondrial TCA cycle,
but also participates in the glyoxylate cycle to provide C4
biosynthetic precursors. The operation of the glyoxylate cycle
requires the transport of intermediates across the peroxisomal
membrane since enzymes of the glyoxylate cycle are located
both inside and outside the peroxisome (Kunze et al., this issue).
The differential localisation of enzymes in plants and fungi
results in different transport requirements for the glyoxylate
cycle: export of citrate and malate and import of oxaloacetate
are common to both plants and fungi, but organisms in which
isocitrate lyase is cytosolic must import glyoxylate whereas
organisms with peroxisomal isocitrate lyase require the import
of isocitrate and export of succinate (Fig. 4). The transport
requirements of the glyoxylate cycle are considered in detail by
Kunze et al. (this issue).
4. Intraperoxisomal pH
The existence of a proton gradient across the peroxisomal
membrane is a long-standing matter of debate and relates to the
question as to whether peroxisomes are impermeable to small
molecules in vivo. Arguments in favour of a peroxisomal pore
with an exclusion size of about 300 Da are presented by
Antonenkov and Hiltunen (this issue). Data supporting the
closed-compartment hypothesis emerged from analyses that
were concerned with the pH of peroxisomes. Early evidence for
a proton gradient across the peroxisomal membrane was
obtained from studies with yeast. Upon induction of Hanse-
nula polymorpha peroxisomes with methanol, a second
phosphate pool became discernible through 31P NMR studies
measuring the pH-dependent chemical shifts of phosphate: in
addition to the cytosolic phosphate peak, a peroxisomal peak
attributable to a lower pH was observed [142]. Furthermore, the
weak base DAMP, which accumulates specifically in acidic
compartments, was detectable in peroxisomes of intact spher-
oplasts by immunocytochemistry [143]. Dissipation of intracel-
lular pH gradients by chloroquine resulted in the disappearance
of the second phosphate peak and DAMP was no longer located
in peroxisomes, consistent with the existence of an endogenous
ΔpH across the peroxisomal membrane. At that time, the
generation of a proton gradient was explained by a (hypothe-
tical) peroxisomal proton-translocating ATPase [144,145], but
the molecular identity of this activity has remained elusive.
More recent in vivo measurements of the peroxisomal pH
have caused considerable confusion. Determination of the
peroxisomal pH in human fibroblasts with a membrane-
permeable peptide harbouring a C-terminal peroxisomal target-
ing signal type 1 (PTS1) and labelled with the pH-sensitive
fluorescent moiety carboxyseminaphtofluorescein (SNAFL-2)
confirmed the existence of a pH gradient, but apparently with a
reversed orientation, i.e. basic inside, with a peroxisomal pH of
8.2 [146]. The gradient could be dissipated by the addition of
uncoupler and was apparently absent in a cell line harbouring a
mutated PEX7, which exhibits a specific import defect of
proteins with a PTS2. The approach used relies on the pH-
dependent emission ratio of the fluorophore at two different
wavelengths and is principally well suited for such measure-
ments. A limitation of the method might arise from the low
intracellular concentration of peptides dispersed throughout the
cytosol, making cytosolic pH measurements troublesome. Its
general applicability is further restricted by the possible
extrusion of these peptides via multiple drug resistance
(MDR) transporters [147] and the uptake of such peptides via
endocytosis in yeast (our unpublished observation).
Variants of GFP allow a similar detection of pH-dependent
emission intensities with the advantage of intracellular protein
expression. Expression of one of these variants, the so-called
ratiometric pHluorin [148] as an SKL-tagged variant in Chinese
hamster ovary (CHO) and human fibroblasts revealed that the
peroxisomal pH adapts to that of the cytosol [149]. As a
consequence, the compartment was classified as being proton-
permeable, not taking into account that changing a gradient on
one side evokes an adjustment on the other side of the
membrane. In apparent contrast, by expressing the same protein
in yeast, a pH value more acidic than that of the cytosol was
determined for peroxisomes [88]. Similar emission ratios of
ratiometric pHluorin were observed for cytosolic and peroxi-
somal variants in both systems, but attempts to calibrate the
system from outside the cell by Jankowski et al. [149] led to a
different interpretation of the results.
Yellow fluorescent protein (YFP) and a point-mutated
version with an altered pKa value were also used to determine
the pH of yeast peroxisomes. Here, the absolute fluorescence
intensity (rather than a ratio of intensities) was correlated with
the pH, which possibly makes the system more vulnerable to
differences in expression and distribution of the fluorescent
protein. The outcome of this study was an alkaline peroxisomal
pH that was even higher in several mutants affected in β-
oxidation, whereas in ant1Δ cells, a pH gradient was not
observed. A hypothesis was put forward that the imposed pH
gradient serves as a driving force for the passive transport of
free MCFAs, which would deprotonate more readily inside
peroxisomes in a basic milieu [89]. However, this idea is hard to
reconcile with the observed depletion of the gradient in the
absence of Ant1p, which increases the lumenal proton
concentration, unless an intraperoxisomal ATP-consuming
reaction or transport process overcompensates this effect.
Support for a basic pH also enters from studies with Penicil-
lium chrysogenum suggesting a slightly alkaline pH for the
microbody lumen in this fungus [150]. Finally, the basic pI of
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several peroxisomal matrix enzymes has been invoked to
support an argument for an alkaline peroxisomal pH [146].
The jury is out there to track down possible caveats in the
various methods applied, which should lead to the desirable
clarification of this issue. An important factor to be considered
in future studies is the influence of growth conditions,
developmental state and cell type on the peroxisomal pH. For
instance, methanol utilisation in H. polymorpha requires an
acidic peroxisomal pH, since the substrate specificity of
dihydroxyacetone synthase requires formaldehyde in its proto-
nated form [151]. What seems clear is that in yeast, Ant1p
contributes to the formation of a pH gradient as a direct
consequence of its proton-compensated transport mode [88].
Although the existence of an H+ATPase is unlikely, additional
factors might contribute to the maintenance of this gradient. To
date it can only be speculated whether a peroxisomal proton
gradient is needed to drive other transport processes, though
physicochemical considerations predict that the existence of a
pH gradient between the cytosol and peroxisomal lumen is
likely to be a key component in determining the extent of
passive transport of free acids across the peroxisomal
membrane.
5. Conclusions and perspectives
Although considerable progress in understanding of perox-
isomal transport processes has been made in recent years, many
questions remain to be resolved. Several novel peroxisomal
transporters have been reported recently, including a Ca2+
ATPase in Drosophila [152] and a peroxisomal protein from
brome grass (Bromus inermis) which is similar to amino acid-
selective channel proteins from the chloroplast outer membrane
[153]. Nevertheless, knowledge of peroxisomal metabolism
predicts the existence of further metabolite transporters
involved in organism-specific peroxisomal processes, in
addition to those mentioned elsewhere in this review.
Identification of such transporters may come from several
approaches, including proteomic analysis of peroxisomal
membrane proteins, forward genetics approaches and char-
acterisation of candidate genes using knock-down systems. A
further, yet exciting, challenge is the rigorous characterisation
of known transporters which will require the development of
transport assays with isolated organelles and reconstituted,
purified proteins. The past few decades have been an exciting
era for peroxisome research and an improved understanding of
peroxisomal transporters will undoubtedly enhance and extend
our appreciation of the functions of this multipurpose
organelle.
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